Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
These patients are more prone to develop acute kidney injury due to dehydration and volume contraction
GLP-1 Medications: Work with natural hunger hormones Multiple complementary mechanisms Target biological causes of overeating Produce 10-22% average weight loss Much more effective than traditional options Medical Uses: FDA-Approved Indications: For Type 2 Diabetes: All GLP-1 medications originally approved for diabetes Improve blood sugar control Reduce A1C by 1-2 percentage points Lower risk of cardiovascular events For Chronic Weight Management: Semaglutide (Wegovy): Approved 2021 Tirzepatide (Zepbound): Approved 2023 Liraglutide (Saxenda): Approved 2014 Requirements for weight loss approval: BMI 30, or BMI 27 with weight-related condition (diabetes, hypertension, sleep apnea, etc.) Off-Label Use: Many doctors prescribe diabetes versions (Ozempic, Mounjaro) off-label for weight loss because: Identical medication to weight loss versions Sometimes better insurance coverage Same effectiveness regardless of indication on label This is legal and common medical practice
Sulistyo A, et al
It contains the same active ingredient, semaglutide, as Ozempic and is also approved for managing type 2 diabetes
US$ 28.78
US$ 27.11
US$ 24.34
US$ 28.15
US$ 26.10
US$ 29.61
US$ 23.44
US$ 28.04
US$ 23.31
US$ 29.70
US$ 27.92
US$ 29.64
